Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Bypass surgery may be better than stents for patients who skip meds

For heart disease patients who adhere to optimal medical therapy, outcomes of coronary bypass graft surgery (CABG) and percutaneous coronary intervention (PCI) may not differ, a new study finds.

Read More »

U.N. legal stance on Haiti cholera likely pushed by U.S.: expert

The United Nations likely refused to accept legal responsibility for a cholera outbreak in Haiti that has killed thousands in the past six years because it was a position pressed by the United States, an independent U.N. investigator said.

Read More »

Ireland joins queue to prise London’s EMA

Ireland is the latest candidate to lure the European Medicines Agency should the EMA uproot from London after Britain’s vote to leave the European Union.

Read More »

Unnamed Fund Manager With Reliable Track Record Says High-Flying Corbus is About to Crash

Shares of Corbus Pharmaceuticals were down more than 20 percent following the publication of an article that said the company was “headed for a big fall.”

Read More »

Watch Out Juno and Kite Pharma: Novartis Clearly Not Done With CAR-T

Reports of the death of Novartis’ CART-T program may have been greatly exaggerated. Despite shutting down its Cell & Gene Therapy Unit, Novartis said it will continue to push its pediatric leukemia therapy CTL019 toward regulatory approval.

Read More »

Tiny Dipexium Craters After Lead Drug Locilex Flunks Phase III Trials

Shares of Dipexium were down more than 80 percent after the company announced its Phase III topical cream Locilex for mild diabetic foot ulcers failed to meet its primary endpoint compared to standardized wound care in two clinical trials.

Read More »

FDA approves Keytruda in untreated lung cancer

Merck & Co. won U.S. approval to market its immunotherapy Keytruda for use in previously untreated lung cancer patients two months ahead of schedule.

Read More »

Benchmark 2017 premiums up 25%

The average premium for benchmark 2017 Obamacare insurance plans sold on rose 25 percent compared with 2016, the U.S. government said, the biggest increase since the insurance first went on sale in 2013 for the following year.

Read More »

Young football players’ brains change after one season

Children’s brains undergo noticeable changes after just one season of football, even if they were never diagnosed with a concussion, according to a new imaging study.

Read More »

Life Care to pay record $145 million over false claims

Life Care Centers of America Inc. and its owner Forrest Preston agreed to pay $145 million to resolve a U.S. lawsuit accusing the company of submitting false claims for rehabilitation therapy services that were not reasonable, necessary or skilled, the U.S. Department of Justice said.

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

December 2018 Focus: Healthcare Agency Roundtable, Mobile Marketing, and more!


Ad Right Bottom